Products / Retatrutide

RETATRUTIDE labelled vial

Retatrutide 10 mg

A peptide investigated for activity at GIP, GLP-1 and glucagon receptors.

CAD $132.00 / vial

Vial amount

Add to cart Ask about this product

The specifics, clearly listed.

Product details

Product reference: MRD-0129 Listed amount per vial: 10 mg Sales unit: 1 vial

Read the research in context.

A peptide investigated for activity at GIP, GLP-1 and glucagon receptors.

  • Coskun et al. LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept. Cell Metabolism, 2022. — source Bibliographic record and indexed abstract verified; direct publisher opening returned 403. Full-text appraisal NOT completed.
  • Jastreboff et al. Triple-Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial. New England Journal of Medicine, 2023. — source Bibliographic record verified; full text and supplements NOT reviewed. No efficacy figures or adverse-event rates carried into this draft.

Access levels: each citation records how much of the source was read. Published findings address the studied material, not this supplied product.

What this doesn’t establish: This is not a comprehensive review of current clinical development. Full text, supplementary material, subsequent publications and corrections have not been fully appraised in this pass. No claims are made about treatment benefit, comparative effectiveness, long-term safety or suitability for an individual.

Product documents

No verified report is available here for this item. Ask about documentation for Retatrutide, product reference MRD-0129.

Before you decide.

Separate research about the compound from evidence about the supplied product.

Which vial amount is shown?

This listing shows 10 mg per vial.

Does the study verify this vial?

No. Research on a compound does not establish the identity, quality, safety or effectiveness of a product sold under that name.

What should I check in a report?

Check the sample identity, batch reference, issuer, date, test methods and results. A report applies to the identified sample and tests.

What information should I request?

Ask about the exact product identity, form, specification, handling requirements and relevant batch documents before deciding.